Literature DB >> 29503157

Chaperone-Independent Peripheral Quality Control of CFTR by RFFL E3 Ligase.

Tsukasa Okiyoneda1, Guido Veit2, Ryohei Sakai3, Misaki Aki3, Takeshi Fujihara3, Momoko Higashi3, Seiko Susuki-Miyata3, Masanori Miyata3, Norihito Fukuda3, Akihiko Yoshida3, Haijin Xu2, Pirjo M Apaja2, Gergely L Lukacs4.   

Abstract

The peripheral protein quality control (QC) system removes non-native membrane proteins, including ΔF508-CFTR, the most common CFTR mutant in cystic fibrosis (CF), from the plasma membrane (PM) for lysosomal degradation by ubiquitination. It remains unclear how unfolded membrane proteins are recognized and targeted for ubiquitination and how they are removed from the apical PM. Using comprehensive siRNA screens, we identified RFFL, an E3 ubiquitin (Ub) ligase that directly and selectively recognizes unfolded ΔF508-CFTR through its disordered regions. RFFL retrieves the unfolded CFTR from the PM for lysosomal degradation by chaperone-independent K63-linked poly-ubiquitination. RFFL ablation enhanced the functional expression of cell-surface ΔF508-CFTR in the presence of folding corrector molecules, and this effect was further improved by inhibiting the Hsc70-dependent ubiquitination machinery. We propose that multiple peripheral QC mechanisms evolved to dispose of non-native PM proteins and to preserve cellular proteostasis, even at the cost of eliminating partially functional polypeptides.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CFTR; cystic fibrosis; endosome; protein quality control; ubiquitination

Mesh:

Substances:

Year:  2018        PMID: 29503157      PMCID: PMC6447300          DOI: 10.1016/j.devcel.2018.02.001

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  26 in total

1.  Trafficking of the human ether-a-go-go-related gene (hERG) potassium channel is regulated by the ubiquitin ligase rififylin (RFFL).

Authors:  Karim Roder; Anatoli Kabakov; Karni S Moshal; Kevin R Murphy; An Xie; Samuel Dudley; Nilüfer N Turan; Yichun Lu; Calum A MacRae; Gideon Koren
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

2.  Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation.

Authors:  Sara Canato; João D Santos; Ana S Carvalho; Kerman Aloria; Margarida D Amaral; Rune Matthiesen; André O Falcao; Carlos M Farinha
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

3.  Transcytosis maintains CFTR apical polarity in the face of constitutive and mutation-induced basolateral missorting.

Authors:  Aurélien Bidaud-Meynard; Florian Bossard; Andrea Schnúr; Ryosuke Fukuda; Guido Veit; Haijin Xu; Gergely L Lukacs
Journal:  J Cell Sci       Date:  2019-05-15       Impact factor: 5.285

4.  Targeting the EGFR-ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del.

Authors:  Jack Wellmerling; Rachael E Rayner; Sheng-Wei Chang; Elizabeth L Kairis; Sun Hee Kim; Amit Sharma; Prosper N Boyaka; Estelle Cormet-Boyaka
Journal:  FASEB J       Date:  2022-05       Impact factor: 5.191

5.  CFTR Rescue by Lumacaftor (VX-809) Induces an Extensive Reorganization of Mitochondria in the Cystic Fibrosis Bronchial Epithelium.

Authors:  Clarissa Braccia; Josie A Christopher; Oliver M Crook; Lisa M Breckels; Rayner M L Queiroz; Nara Liessi; Valeria Tomati; Valeria Capurro; Tiziano Bandiera; Simona Baldassari; Nicoletta Pedemonte; Kathryn S Lilley; Andrea Armirotti
Journal:  Cells       Date:  2022-06-16       Impact factor: 7.666

6.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

7.  ELISA Based Protein Ubiquitylation Measurement.

Authors:  Yuka Kamada; Ryosuke Fukuda; Tsukasa Okiyoneda
Journal:  Bio Protoc       Date:  2019-11-20

Review 8.  Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer.

Authors:  Ryosuke Fukuda; Tsukasa Okiyoneda
Journal:  Front Pharmacol       Date:  2018-09-27       Impact factor: 5.810

Review 9.  Assistance for Folding of Disease-Causing Plasma Membrane Proteins.

Authors:  Karina Juarez-Navarro; Victor M Ayala-Garcia; Estela Ruiz-Baca; Ivan Meneses-Morales; Jose Luis Rios-Banuelos; Angelica Lopez-Rodriguez
Journal:  Biomolecules       Date:  2020-05-07

Review 10.  Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.

Authors:  Matthew D Strub; Paul B McCray
Journal:  Genes (Basel)       Date:  2020-05-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.